Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Takeda Pharmaceutical Co., Ltd. et al v. Anchen Pharmaceuticals, Inc.
Case Number:
3:11-cv-01609
Court:
Nature of Suit:
Judge:
Firms
Companies
- Anchen Pharmaceuticals Inc.
- Impax Laboratories, Inc.
- Par Pharmaceutical Cos. Inc.
- Takeda Pharmaceutical Co. Ltd.
Sectors & Industries:
-
November 04, 2013
Takeda Triumphs In Suits To Block Generic Dexilant
Takeda Pharmaceutical Co. Ltd. on Friday scored victories in three of its patent infringement suits in California federal court against drugmakers looking to sell a generic version of its acid reflux medicine Dexilant, convincing the court that a total of four of its patents would be infringed if the generics went to market.
-
November 16, 2012
Takeda Drops Some Infringement Claims In Dexilant Suit
Takeda Pharmaceutical Co. Ltd. has determined that a generic rival's pursuit of a competing version of the Dexilant acid reflux treatment does not infringe a handful of its patents, according to a California federal court's Friday filing entering judgment for the generic drugmaker for four of Takeda's six asserted patents.